Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Lyra Therapeutics (LYRA) is now available.
Edward T. Anderson has stepped down from his roles on the Board of Directors and its Audit and Compensation Committees at Lyra Therapeutics, Inc., where he has served since 2019, after being an investor and adviser since 2006. The company expressed gratitude for his contributions and appointed Nancy L. Snyderman to the Audit Committee in his stead.
For a thorough assessment of LYRA stock, go to TipRanks’ Stock Analysis page.